Amgen Inc. Profile Avatar - Palmy Investing

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…

Drug Manufacturers - General
US, Thousand Oaks [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Amgen Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Amgen Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Amgen Inc..

End of AMGN's Analysis
CIK: 318154 CUSIP: 031162100 ISIN: US0311621009 LEI: - UEI: -
Secondary Listings